Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT00978432
Title Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Anne Beaven, MD
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Duke University Medical Center Durham North Carolina 27710 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field